High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system

K Kario1, T Matsuo

  • 1Department of Internal Medicine, Awaji-Hokutan Public Clinic, Hokutan, Japan.

Insights

High factor-VII activity in elderly individuals is linked to increased risks of vascular disease. This condition is associated with elevated cholesterol and signs of coagulation activation, not endothelial cell injury.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Geriatrics

Background:

  • High factor-VII activity is an emerging risk factor for coronary artery disease.
  • The study investigates the link between high factor-VII activity, endothelial cell injury, and coagulation in the elderly.

Purpose of the Study:

  • To determine if high factor-VII activity in elderly patients stems from endothelial cell injury.
  • To assess if high factor-VII activity contributes to vascular disease via coagulation system activation.

Main Methods:

  • Compared 27 healthy elderly men with high factor-VII activity to 22 with low activity.
  • Included 36 patients with existing vascular disease (coronary artery disease, cerebral infarction).
  • Measured endothelium-derived markers, coagulation inhibitors, activation markers, lipoprotein (a), and cholesterol levels.

Main Results:

  • Endothelial cell injury markers did not differ between high and low factor-VII activity groups.
  • High factor-VII activity group showed higher levels of coagulation inhibitors, activation markers, lipoprotein (a), and total cholesterol.
  • Vascular disease patients exhibited coagulation and lipid profiles closer to the high factor-VII group.

Conclusions:

  • High factor-VII activity in the elderly is not primarily caused by endothelial cell injury.
  • It is associated with hyperlipidemia (including lipoprotein (a)) and in vivo coagulation activation.
  • Elderly individuals with high factor-VII activity have a predisposition to vascular disease.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...